Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ¥154,401.98, with a 24-hour trading volume of ¥87.1B. The asset's market cap is ¥138.31T, after moving 0.50% in the last day.
Tokenized Eli Lilly And Co is trading at ¥154,683.93, with a tokenized market cap of ¥824.13M and a 24-hour trading volume of ¥476.63M. The tokenized asset has moved -1.60% in the past 24 hours.